It has been just over 10 days since President Donald Trump signed this Executive Order today, titled “Increasing Medical Marijuana And Cannabidiol Research” (basics here). As noted in this prior post, I have been struck by the relative lack of media coverage of this historic shift in federal drug policy announced by a headline-generating president.
That said, there still has been a number of notable recent press pieces about what contributed to Prez Trump’s decision to sign this EO and also about what may come next. Here is a round up of some of these pieces:
Backstories
From High Times, “How the Cannabis Lobby Finally Got Trump to Budge“
From the Wall Street Journal, “How Trump Became the Unlikely Champion of Easing Marijuana Restrictions“
From the Washington Times, “Marijuana companies spent millions on lobbying ahead of Trump rescheduling order“
Future Stories
From Forbes, “Reclassifying Cannabis In 2026 Means Big Changes For The Workplace“
From JD Supra, “President Trump’s Cannabis Rescheduling Order: Implications for employment law and workplace practice“
From MJBiz Daily, “Great leaps in cannabis research expected after marijuana rescheduling“
From NPR, “Marijuana rescheduling would bring some immediate changes, but others will take time“